Markus Böhm (M Böhm)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 14

Top Topics

Transforming Growth Factor

Rheumatoid Arthritis Patients

Top Venues

Experimental dermatology

Journal of the European Academy of Dermatology and Venereology : JEADV

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG

The British journal of dermatology

This page only lists publications with an associated author ORCID identifier.

Publications

Laura Bültmann, Dieter Metze, Markus Böhm
Skin-colored asymptomatic papules since adolescence. Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG (2024)
Markus Böhm, Rachel Sommer, Uwe Gieler, Petra Staubach, Alexander Zink, Christian J Apfelbacher, Eva M J Peters
Vitiligo - a disease: A position paper on stigmatization, life quality impairment and psychosocial comorbidity. Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG (2024)
Markus Böhm, C Robert, S Malhotra, K Clément, S Farooqi
An overview of benefits and risks of chronic melanocortin-1 receptor activation. Journal of the European Academy of Dermatology and Venereology : JEADV (2024)
Julien Seneschal, Reinhart Speeckaert, Alain Taieb, Albert Wolkerstorfer, Thierry Passeron, Amit G Pandya, Henry W Lim, Khaled Ezzedine, Youwen Zhou, Leihong Flora Xiang, Steven Thng, Atsushi Tanemura, Tamio Suzuki, David Rosmarin, Michelle Rodrigues, Noufal Raboobee, Georg Pliszewski, Davinder Parsad, Naoki Oiso, Paul Monteiro, Jean Marie Meurant, Nicolle Maquignon, Harvey Lui, Caroline Le Poole, Giovanni Leone, Ai-Young Lee, Cheng-Che Eric Lan, Ichiro Katayama, Richard Huggins, Sang Ho Oh, John E Harris, Iltefat H Hamzavi, Somesh Gupta, Pearl Grimes, Boon Kee Goh, Deepti Ghia, Samia Esmat, Viktoria Eleftheriadou, Markus Böhm, Laila Benzekri, Marcel Bekkenk, Jung Min Bae, Augustin Alomar, Marwa Abdallah, Mauro Picardo, Nanja van Geel
Worldwide expert recommendations for the diagnosis and management of vitiligo: Position statement from the international Vitiligo Task Force-Part 2: Specific treatment recommendations. Journal of the European Academy of Dermatology and Venereology : JEADV (2023)
Nanja van Geel, Reinhart Speeckaert, Alain Taieb, Khaled Ezzedine, Henry W Lim, Amit G Pandya, Thierry Passeron, Albert Wolkerstorfer, Marwa Abdallah, Augustin Alomar, Jung Min Bae, Marcel Bekkenk, Laila Benzekri, Markus Böhm, Viktoria Eleftheriadou, Samia Esmat, Deepti Ghia, Boon Kee Goh, Pearl Grimes, Somesh Gupta, Iltefat H Hamzavi, John E Harris, Sang Ho Oh, Richard Huggins, Ichiro Katayama, Cheng-Che Eric Lan, Ai-Young Lee, Giovanni Leone, Caroline Le Poole, Harvey Lui, Nicolle Maquignon, Jean Marie Meurant, Paul Monteiro, Naoki Oiso, Davinder Parsad, Georg Pliszewski, Noufal Raboobee, Michelle Rodrigues, David Rosmarin, Tamio Suzuki, Atsushi Tanemura, Steven Thng, Leihong Flora Xiang, Youwen Zhou, Mauro Picardo, Julien Seneschal
Worldwide expert recommendations for the diagnosis and management of vitiligo: Position statement from the International Vitiligo Task Force Part 1: towards a new management algorithm. Journal of the European Academy of Dermatology and Venereology : JEADV (2023)
Julia Schmitz, Markus Böhm
Is Fas-mediated apoptosis of melanocytes indispensable in vitiligo? Experimental dermatology (2021)
Nicoline F Post, Rosalie M Luiten, Albert Wolkerstorfer, Marcel W Bekkenk, Markus Böhm
Does autoimmune vitiligo protect against COVID-19 disease? Experimental dermatology 30 (9) (2021)
Agatha Stegemann, Markus Böhm
Targeting the α7 nicotinic acetylcholine receptor-A novel road towards the future treatment of skin diseases. Experimental dermatology 29 (9) (2020)
Konrad Kleszczyński, Markus Böhm
Can melatonin and its metabolites boost the efficacy of targeted therapy in patients with advanced melanoma? Experimental dermatology 29 (9) (2020)
Markus Böhm, E H Kemp, D Metze, A M Muresan, M Neufeld, R M Luiten, T Ruck
Alemtuzumab-induced halo naevus-like hypopigmentation - new insights into secondary skin autoimmunity in response to an immune cell-depleting antibody. Journal of the European Academy of Dermatology and Venereology : JEADV 35 (1) (2020)
Markus Böhm, Thomas Luger
Are melanocortin peptides future therapeutics for cutaneous wound healing? Experimental dermatology 28 (3) (2019)
Agatha Stegemann, Markus Böhm
Tropisetron via α7 nicotinic acetylcholine receptor suppresses tumor necrosis factor-α-mediated cell responses of human keratinocytes. Experimental dermatology 28 (3) (2019)
P Gkogkolou, M Sarna, T Sarna, R Paus, T A Luger, Markus Böhm
Protection of glucotoxicity by a tripeptide derivative of α-melanocyte-stimulating hormone in human epidermal keratinocytes. The British journal of dermatology 180 (4) (2018)
Markus Böhm, A Stegemann, D Metze, K Scharffetter-Kochanek, A Sindrilaru
The mammalian target of rapamycin inhibitor everolimus suppresses proliferation, metabolic activity and collagen synthesis of human fibroblasts in vitro and exerts antifibrogenic effects in vivo. The British journal of dermatology 177 (4) (2017)